© 1996 Oxford University Press
research-article |
Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients
1Department of Community, Environmental and Occupational, Medicine, Ein Shams University Cairo, Egypt
2Department of Preventive Medicine and Community Health
3Department of Human Biological Chemistry and Genetics, University of Texas Medical Branch Galveston, TX 77555-1110, USA
4Department of Surgery, National Cancer Institute Cairo, Egypt
5To whom correspondence should be addressed
Polymorphic changes in the GSTM1, CYP2E1 and the CYP2D6 genes have been reported to be individually associated with increased susceptibility to certain cancers. In the present study, the relationship between genetic polymorphism for these genes and development of urinary bladder cancer among Egyptian patients was investigated. Our results indicate that the frequency of bladder cancer patients with the GSTM1 null genotype is significantly higher than that of the normal controls (86.3 and 47.6%, respectively) with an odds ratio (OR) of 6.97 (95% CL = 1.59–30.57, Fisher's exact P = 0.008). In contrast, our investigation failed to demonstrate any difference in the distribution of CYP2E1 polymorphism between bladder cancer patients and controls as detected by PstI restriction fragment length polymorphism (RFLP) analysis. RFLP analysis of the CYP2D6 gene revealed a non-significant increase in the number of extensive metabolizers (EM) among the patients compared to the controls (68 versus 48%). However, the EM genotypes enhances the risk further for individuals harboring the GSTM1 null genotype as individuals harboring both the EM and the GSTM1 null genotypes have an odds ratio of 14.0 (95% CL = 1.3–151.4, Fisher's exact P = 0.02) compared to individuals harboring the EM and the GSTM1+/+ genotypes. In conclusion, our results indicate that genetic polymorphism, especially in GSTM1 and CYP2D6 could play an important role as host risk factors for development of urinary bladder cancer among Egyptians.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. M. N. Garcia, O. A. Curioni, M. B. de Carvalho, and G. J. F. Gattas Polymorphisms in Alcohol Metabolizing Genes and the Risk of Head and Neck Cancer in a Brazilian Population Alcohol Alcohol., November 3, 2009; (2009) agp078v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Burim, R. Canalle, A. d. L. C. Martinelli, and C. S. Takahashi Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics Mutagenesis, July 1, 2004; 19(4): 291 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang and G. B. Gordon A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway Mol. Cancer Ther., July 1, 2004; 3(7): 885 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Barnette, R. Scholl, M. Blandford, L. Ballard, A. Tsodikov, J. Magee, S. Williams, M. Robertson, F. Ali-Osman, R. Lemons, et al. High-Throughput Detection of Glutathione S-Transferase Polymorphic Alleles in a Pediatric Cancer Population Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 304 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Engel, E. Taioli, R. Pfeiffer, M. Garcia-Closas, P. M. Marcus, Q. Lan, P. Boffetta, P. Vineis, H. Autrup, D. A. Bell, et al. Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review Am. J. Epidemiol., July 15, 2002; 156(2): 95 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gao, T. Takezaki, J. Wu, Z. Li, J. Wang, J. Ding, Y. Liu, X. Hu, T. Xu, K. Tajima, et al. Interaction between Cytochrome P-450 2E1 Polymorphisms and Environmental Factors with Risk of Esophageal and Stomach Cancers in Chinese Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 29 - 34. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Brooks, V. G. Paton, and G. Vidanes Potent Induction of Phase 2 Enzymes in Human Prostate Cells by Sulforaphane Cancer Epidemiol. Biomarkers Prev., September 1, 2001; 10(9): 949 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.E. Johns and R.S. Houlston Glutathione S-transferase {micro}1 (GSTM1) status and bladder cancer risk: a meta-analysis Mutagenesis, September 1, 2000; 15(5): 399 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Tan, N. Song, G.-Q. Wang, Q. Liu, H.-J. Tang, F. F. Kadlubar, and D.-X. Lin Impact of Genetic Polymorphisms in Cytochrome P450 2E1 and Glutathione S-Transferases M1, T1, and P1 on Susceptibility to Esophageal Cancer among High-Risk Individuals in China Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 551 - 556. [Abstract] [Full Text]
|
|
|
|
|
|
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. P. Bennett, M. C. R. Alavanja, B. Blomeke, K. H. Vahakangas, K. Castren, J. A. Welsh, E. D. Bowman, M. A. Khan, D. B. Flieder, and C. C. Harris Environmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women J Natl Cancer Inst, December 1, 1999; 91(23): 2009 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Nazar-Stewart, T. L. Vaughan, R. D. Burt, C. Chen, M. Berwick, and G. M. Swanson Glutathione S-Transferase M1 and Susceptibility to Nasopharyngeal Carcinoma Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 547 - 551. [Abstract] [Full Text]
|
|